|
Video: What is a Stock Split?
|
|
Aadi Bioscience is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Co.'s primary drug product, FYARRO, is a form of sirolimus bound to albuminnab. Co. is studying FYARRO in cancers with known mTOR pathway activation, including tumor-agnostic indications targeting specific genomic alterations that activate the mTOR pathway. In addition, Co. has ongoing studies as well as studies in planning for testing the safety and efficacy of FYARRO in combination with other targeted agents, such as Co.'s exisitng collaboration with Mirati Therapeutics, Inc. According to our Aadi Bioscience stock split history records, Aadi Bioscience has had 1 split. | |
|
Aadi Bioscience (AADI) has 1 split in our Aadi Bioscience stock split history database. The split for AADI took place on August 27, 2021. This was a 1 for 15 reverse split, meaning for each 15 shares of AADI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as Aadi Bioscience conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Aadi Bioscience stock split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aadi Bioscience shares, starting with a $10,000 purchase of AADI, presented on a split-history-adjusted basis factoring in the complete Aadi Bioscience stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/20/2018 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$66.00 |
|
End price/share: |
$1.90 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.12% |
|
Average Annual Total Return: |
-43.73% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$287.90 |
|
Years: |
6.17 |
|
|
|
Date |
Ratio |
08/27/2021 | 1 for 15 |
|
|